logo-loader
RNS
Mediclinic International Plc

Director/PDMR Shareholding

/**/ h1{margin:0cm;margin-bottom:.0001pt;line-height:115%;font-size:10.0pt;font-family:"Arial","sans-serif";}em{font-family:"Arial","sans-serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: purple } .ae{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.ae{}p.aa,li.aa,div.aa{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Times New Roman","serif";color:#72665B;}span.bs{font-family:"Arial","sans-serif"; color:windowtext}p.bu{margin-top:10.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:110%;font-size:10.0pt;font-family:"Arial","sans-serif";margin-top:0cm;line-height:normal}span.bq{font-family: "Arial","sans-serif";color:windowtext}span.bp{font-family:"Arial","sans-serif";color:windowtext}p.bv{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;line-height:12.65pt}span.bw{font-size:10.0pt;font-family:"Arial","sans-serif"}p.bx{margin-top:10.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:110%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; margin-top: 0cm; text-align: center} span.bm{line-height:110%}span.u{}p.by{margin-top:10.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:110%;font-size:10.0pt;font-family:"Arial","sans-serif";margin-top:0cm;text-align:justify}p.bz{margin-top:10.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:110%;font-size:10.0pt;font-family:"Arial","sans-serif";margin-top:0cm}table.ca{border-collapse:collapse;border:none}td.bh{width:24.65pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.cb{margin-top:4.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;font-size:10.0pt;font-family:"Arial","sans-serif";margin:0cm;margin-bottom:.0001pt}td.bf{width:407.35pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}p.cc{margin-top:4.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;font-size:10.0pt;font-family:"Arial","sans-serif";font-div: italic; margin: 0cm; margin-bottom: .0001pt}td.be{width:24.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt} td.bd{width:95.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ba{width:301.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}em.bb{font-weight: bold}span.bc{font-div:normal}td.az{width:407.35pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}span.v{}p.cd{margin-top:4.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;font-size:10.0pt;font-family:"Arial","sans-serif";margin:0cm;margin-bottom:.0001pt;text-align:justify}p.ce{margin-top:4.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;font-size:10.0pt;font-family:"Arial","sans-serif";font-div: italic; font-weight: bold; margin: 0cm; margin-bottom: .0001pt}p.cf{margin-top:4.0pt;margin-right:0cm;margin-bottom:4.0pt;margin-left:0cm;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt}tr.an{page-break-inside:avoid;height:47.0pt} td.av{width:24.65pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:47.0pt}td.au{width:95.5pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:47.0pt}td.ao{width:301.05pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt;height:47.0pt}td.at{width:47.62%;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.as{width:52.38%;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.ar{width:47.62%;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}td.aq{width:52.38%;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}tr.am{page-break-inside:avoid}p.cg{margin-top:10.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:110%;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold; line-height: normal; margin-top: 0cm; text-align: justify}p.ch{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Times New Roman","serif";color:#72665B;text-align:justify;line-height:115%} h1.aj{line-height:normal}p.ci{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";font-weight: bold}p.g,li.g,div.g{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Arial","sans-serif";}span.ah{font-family:"Arial","sans-serif"}span.ag{color:windowtext}span.af{font-family:"Arial","sans-serif"; font-weight:normal} /**/
RNS Number : 6340C
Mediclinic International plc
18 June 2019
 

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC

JSE Share Code: MEI
NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic", the "Company" or the "Group")

 

18 June 2019

 

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

On 14 June 2019, Mr Jurgens Myburgh, Chief Financial Officer of Mediclinic International plc, acquired 3,000 shares in the Company at ZAR 57.14 per share. Accordingly, Mr Myburgh now owns a total of 83,000 shares in Mediclinic International plc.

 

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

 

1.

Details of PDMR / persons closely associated with them ("PCA")

 

a)

Name

Mr Petrus Jurgens Myburgh

 

2.

Reason for the notification

 

a)

Position / status

Chief Financial Officer of the Company

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Purchase of shares

 

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

ZAR 57.14 per share

3,000

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

3,000

 

ZAR 57.14

 

 

e)

Date of the transaction

14 June 2019; 07:24 UTC

 

 

f)

Place of the transaction

Johannesburg Stock Exchange

 

 

 

 

About Mediclinic International plc

 

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates.

 

The Group's core purpose is to enhance the quality of life.

 

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.

 

Mediclinic comprises 77 hospitals, five sub-acute hospitals, 12 day case clinics and 21 outpatient clinics. Hirslanden operates 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operates 52 hospitals, five sub-acute hospitals and 12 day case clinics with more than 8 500 inpatient beds; and Mediclinic Middle East operates seven hospitals, two day case clinics and 21 outpatient clinics with more than 900 inpatient beds in the United Arab Emirates.

 

The Company's primary listing is on the London Stock Exchange ("LSE") in the United Kingdom, with secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia.

 

Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.

 

For further information, please contact:

 

Company Secretary, Link Company Matters Limited

Jayne Meacham / Caroline Emmet

+44 (0)20 7954 9569

 

Investor queries

James Arnold, Head of Investor Relations, Mediclinic International plc

+44 (0)20 3786 8181

[email protected] 

 

Media queries

FTI Consulting

Deborah Scott/Brett Pollard - United Kingdom

+44 (0)20 3727 1000

Sherryn Schooling - South Africa

+27 (0)21 487 9000

 

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

Website: www.mediclinic.com

Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBGGDLRDBBGCI

Quick facts: Mediclinic International Plc

Price: £3.19

Market: LSE
Market Cap: £2.35 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE